z-logo
open-access-imgOpen Access
IMMUNOLOGICAL MARKERS OF LONG-TERM EFFECTS OF TREATMENT IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT
Author(s) -
Sergey Krynskiy,
С А Крынский,
И К Малашенкова,
И К Малашенкова,
N A Hailov,
Н. А. Хайлов,
Daniil Ogurtsov,
Daniil Ogurtsov,
Ekaterina Chekulaeva,
Ekaterina Chekulaeva,
Е. В. Пономарева,
Е. В. Пономарева,
С. И. Гаврилова,
С. И. Гаврилова,
Nikolay Didkovsky,
Н А Дидковский
Publication year - 2019
Publication title -
medicinskij akademičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2687-1378
pISSN - 1608-4101
DOI - 10.17816/maj191s184-86
Subject(s) - medicine , cerebrolysin , neuropsychology , systemic inflammation , inflammation , immune system , brain derived neurotrophic factor , neurotrophic factors , immunology , oncology , cognition , psychiatry , receptor
The goal of this research was to study the clinical efficacy of course-based neurotrophic therapy in mild cognitive impairment (MCI) and the effect of therapy on immune parameters in patients, and to assess the prognostic value of the dynamics of immune parameters during the year after treatment. 20 patients with MCI receiving intravenous Cerebrolysin (20 infusions of 30 ml with increasing dose during the first four days) were examined. Neuropsychological and immunological examination was carried out immediately before the study, after 3 months., 6 months and after 1 year after the end of treatment. It was found that after therapy, patients had a long-term decrease in the severity of systemic inflammatory response, and that marked signs of systemic inflammation at the beginning of follow-up combined with a persistent decrease in the level of immunoglobulin G in dynamics were prognostic markers of MCI progression. In conclusion, it wass shown that neurotrophic therapy has a good clinical effect and has a favorable immunomodulatory effect in aMCI, and the relationship between the dynamics of humoral immunity and systemic inflammation and the risk of progression of cognitive impairment in patients within 1 year after therapy was established.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here